Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-15 Veinrib Gadi Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Seehra Jasbir Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Rubin Steven D Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Pontifax Management III G.P. (2011) Ltd. 10% owner Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Pontifax Management III G.P. (2011) Ltd. 10% owner Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Pontifax Management 4 G.P. (2015) Ltd. 10% owner Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Pontifax Management 4 G.P. (2015) Ltd. 10% owner Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Nussbaum Ran Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Noiman Silvia Chief Executive Officer Grant or award +141,389 141,389
2018-06-15 Noiman Silvia Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +141,389 141,389
2018-06-15 Noiman Silvia Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Kleijwegt Martijn Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-15 Kariv Tomer Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-06 Noiman Silvia Chief Executive Officer Option exercise +349,400 $0.00 $210 490,789
2018-06-06 Noiman Silvia Chief Executive Officer Option exercise · Stock Option (Right to Buy) −349,400 0
2018-05-22 Ward Robert Chief Executive Officer Purchase +5,000 $14.34 $72K 15,000
2018-05-16 Huertas Pedro Chief Medical Officer Grant or award +33,000 137,725
2018-05-11 Huertas Pedro Chief Medical Officer Grant or award +104,725 104,725
2018-05-10 Huertas Pedro Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +104,725 104,725
2018-04-30 Shabtai Gilad 10% owner Purchase +75,000 $9.75 $731K 3,351,770

Page 14 of 20 · 388 trades